| Product NDC: | 0832-0111 |
| Proprietary Name: | Amantadine Hydrochloride |
| Non Proprietary Name: | amantadine hydrochloride |
| Active Ingredient(s): | 100 mg/1 & nbsp; amantadine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0832-0111 |
| Labeler Name: | Upsher-Smith Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076186 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111215 |
| Package NDC: | 0832-0111-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (0832-0111-50) |
| NDC Code | 0832-0111-50 |
| Proprietary Name | Amantadine Hydrochloride |
| Package Description | 500 TABLET in 1 BOTTLE (0832-0111-50) |
| Product NDC | 0832-0111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amantadine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111215 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc |
| Substance Name | AMANTADINE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |